Hypertension and the development of heart failure

Journal of Cardiovascular Pharmacology

Volumn 32, Issue SUPPL. 1, 1998, Pages

  De Leeuw, Peter W ^a   Kroon, Abraham A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac function; Heart failure; Hypertension; Left ventricular hypertrophy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CELL INFILTRATION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

EID: 0031690591     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800003-00003     Document Type: Conference Paper

References (59)

1. Janeway T. A clinical study of hypertensive cardiovascular disease. Arch Intern Med 1913;12:755-98.
2. Flaxman N. The course of hypertensive heart disease: 1. Age of onset, development of cardiac insufficiency, duration of life? and cause of death. Ann Intern Med 1936;10:748-53.
3. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham study - 30 years of follow-up. Hypertension 1989; 13(Suppl I):I-13-8.
4. MacMahon S. Blood pressure and the risk of cardiovascular disease. In: Swales JD, ed. Textbook of hypertension. Oxford: Blackwell Scientic Publications, 1994:46-57.
5. Phillips RA, Diamond JA. Hypertensive heart disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996:275-301.
6. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
7. Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation of the cardiovascular system. An international perspective. J Am Coll Cardiol 1992;20:3-16.
8. Schwartzkopff B, Motz W, Vogt M, Strauer BE. Heart failure on the basis of hypertension. Circulation 1993;87(suppl IV):IV-66-72.
9. Schwartzkopff B, Frenzel H, Dieckerhoff J, et al. Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J 1992;13(suppl D): 17-23.
10. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984;69:1-7.
11. Van Hoeven KH, Factor S. Endomyocardial biopsy diagnosis of small vessel disease: a clinicopathologic study. Int J Cardiol 1990;26:103-10.
12. Schwartzkopff B, Motz W, Knauer S, Frenzel H, Strauer BE. Morphometric investigation of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy. J Cardiovasc Pharmacol 1992; 20(suppl 1):12-7.
13. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structure and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension Circulation 1993;88:993-1003.
14. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med 1992;327:998-1008.
15. Devereux RB, Roman MJ. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1995:409-32.
16. Devereux RB, Pickering TG, Harshfield GA, Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regular recurring stress. Circulation 1983;68: 470-6.
17. Guerrier M, Schillaci G, Verdecchia P, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.
18. Julius S, Li Y, Brant D, Krause L, Buda AJ. Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989;13:422-9.
19. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995;6: 413-9.
20. White WB, Schulman P, McCabe E, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989;261:873-7.
21. Cuspidi C, Marabini M, Lonati L, et al. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens 1995;13:1707-10.
22. Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993;21:836-44.
23. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993;22:826-31.
24. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BE. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988;78:951-6.
25. Liebson PR, Grandits G, Prineas R. et al. Echocardiographic correlates of LV structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87:476-86.
26. Brush JE Jr, Cannon RO III, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-7.
27. Houghton JL, Frank MJ, Carr AA, Von Dohlen JW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990;15:43-51.
28. Polese A, De Cesare N, Montorsi P, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991; 83:845-53.
29. Goldstein RA, Haynie M. Limited myocardial perfusion reserve in patients with left ventricular hypertrophy. J Nucl Med 1990;31: 255-8.
30. Antony I, Nitenberg A, Foult J-M, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993;22: 514-20.
31. Tomanek RJ, Palmer PY, Pfeiffer GL, Schreiter KL, Eastham CL, Marcus M. Morphometry of canine coronary arteries, anerioles and capillaries during hypertension and left ventricular hypertrophy. Circ Res 1986;58:38-46.
32. Motz W, Vogt M, Rabenau O, Sender S. Lückhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991;68:996-1003.
33. Brush JE Jr, Faxon DP, Salmon S, Jakobs AK, Ryan TJ. Abnormal endothelial-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-15.
34. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
35. French JK, Elliott JM, Williams BF, Nixon DJ, Denton MA, White HD. Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension. Am J Cardiol 1993;71:505-10.
36. Hedblad B, Janzon L. Hypertension and ST segment depression during ambulatory electrocardiographic recording. Results from the prospective population study 'men bom in 1914' from Malmö, Sweden. Hypertension 1992;20:32-7.
37. Pringle SD, Dunn FG, Tweddel AC, et al. Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J 1992;67:377-82.
38. Zehender M, Meinertz T, Hohnloser S, et al. Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension. Circulation 1992;85:1808-15.
39. Scheler S, Motz W, Vester J, Strauer BE. Transient myocardial ischemia in hypertensive heart disease. Am J Cardiol 1990;65: 51G-5G.
40. Dunn FG, Pringle SD. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy. J Hypertens 1993;11:1003-10.
41. De Simone G, Di Lorenzo L, Costantino G, Moccia D, Buonissimo S, De Divitiis O. Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension 1988;11: 457-63.
42. Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 1995;13:943-52.
43. Phillips RA, Goldman ME, Ardeljan M, et al. Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol 1989;14:979-85.
44. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984;3:1500-6.
45. Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 1986;8:1449-54.
46. Fouad-Tarazi FM. Left ventricular diastolic dysfunction in hypertension. Curr Opin Cardiol 1994;9:551-60.
47. Gerstenblith G, Frederiksen J, Yin FCP, Fortuin NJ, Lakatta EG, Weisfeldt ML. Echocardiographic assessment of a normal adult aging population. Circulation 1977;56:273-8.
48. Lorell BH, Grice WN, Apstein CS. Influence of hypertension with minimal hypertrophy on diastolic function during demand ischemia. Hypertension 1989;13:361-70.
49. Lenihan DJ, Gerson MC, Dorn GW II, Holt BD, Walsh RA. Effects of changes in atrioventricular gradient and contractility on left ventricular filling in human diastolic cardiac dysfunction. Am Heart J 1996;132:1179-88.
50. Moser M, Herben PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-8.
51. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281-5.
52. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;266:3255-64.
53. Doyle AE. Does hypertension predispose to coronary disease? Conflicting epidemiological and experimental evidence. Am J Hypertens 1988;1:319-24.
54. Yusuf S, Thom T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989;13(suppl I):I-74-9.
55. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
56. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
57. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13.
58. Fagard RH. Reversibility of left ventricular hypertrophy by antihypertensive drugs. Neth J Med 1995;47:173-9.
59. Liebson PR, Grandits GA, Dianzumba S, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995;91:698-706.